Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aridis Pharmaceuticals Inc (NQ: ARDS ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 18, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Aridis Pharmaceuticals Inc < Previous 1 2 3 4 5 6 Next > Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation December 12, 2022 From Aridis Pharmaceuticals, Inc. Via GlobeNewswire Aridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan-Ebola and Pan-Marburg Monoclonal Antibody Programs from Mapp Biopharmaceutical December 05, 2022 From Aridis Pharmaceuticals, Inc. Via GlobeNewswire Aridis Announces a Key Milestone of Closing of Patient Enrollment in the Phase 2a Study of AR-501 in Cystic Fibrosis Patients November 30, 2022 From Aridis Pharmaceuticals, Inc. Via GlobeNewswire Aridis Pharmaceuticals Return On Capital Employed Overview August 17, 2022 Via Benzinga Aridis' Inhaled Pan-Coronavirus Antibody Cocktail Shows Encouraging Preclinical Action August 10, 2022 Via Benzinga Aridis to Participate in Key Opinion Leader Discussion on Immunotherapy for Infectious Diseases November 22, 2022 From Aridis Pharmaceuticals, Inc. Via GlobeNewswire Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update November 21, 2022 From Aridis Pharmaceuticals, Inc. Via GlobeNewswire A Novel Immunotherapy That Could Bring Hope To Millions Of Sepsis Patients Received MultiCountry Clearance For Expanded Clinical Trial November 01, 2022 Enlivex Therapeutics Ltd. (NASDAQ: ENLV) announced that Israel, Spain and Greece have cleared amendments to the company’s Phase II trial protocol that will allow the study to enroll more patients. Via Benzinga Recap: Aridis Pharmaceuticals Q1 Earnings May 16, 2022 Aridis Pharmaceuticals (NASDAQ:ARDS) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session September 28, 2022 Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session September 27, 2022 Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million. Via Benzinga Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket September 27, 2022 Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for... Via Benzinga Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday September 27, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session August 24, 2022 Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The market value of their outstanding shares is at $31.6 million. Via Benzinga Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday August 23, 2022 Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 22, 2022 Via Benzinga Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session August 22, 2022 Losers Via Benzinga Recap: Aridis Pharmaceuticals Q2 Earnings August 16, 2022 Aridis Pharmaceuticals (NASDAQ:ARDS) reported its Q2 earnings results on Tuesday, August 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Aridis... Via Benzinga Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial August 10, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday August 01, 2022 Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings... Via Benzinga This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday July 29, 2022 Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session July 28, 2022 Via Benzinga Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session July 28, 2022 Gainers Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday July 25, 2022 Good morning, investor! We're starting off this week of trading with a look at the biggest pre-market stock movers for Monday! Via InvestorPlace 12 Health Care Stocks Moving In Friday's Pre-Market Session July 01, 2022 Via Benzinga RedChip Interviews Aridis Pharmaceuticals' CEO Vu Truong June 30, 2022 ORLANDO, FL / ACCESSWIRE / June 30, 2022 / RedChip Companies will air a new C-Level interview with Aridis Pharmaceuticals (NASDAQ:ARDS) on The RedChip Money Report® on Bloomberg TV, this Saturday, July... From RedChip Via AccessWire Exposures COVID-19 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 16, 2022 Via Benzinga 91 Biggest Movers From Friday June 13, 2022 Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session June 10, 2022 Via Benzinga 76 Biggest Movers From Yesterday May 19, 2022 Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
